Psychedelic Medicine

Association

Psychedelic-Assisted Therapy for People with Eating Disorders

Excerpts from the publication

Purpose of Review
A growing body of research suggests psychedelic-assisted therapy (PAT) may be safe and effective for a variety of mental health conditions. Among these, eating disorders have been a recent target of interest. This review provides an up-to-date summary of the potential mechanisms and use of PAT in people diagnosed with eating disorders, with a focus on anorexia nervosa.

Recent Findings
Classic psychedelics may have transdiagnostic efficacy through several mechanisms relevant to eating disorder pathology. Interest in, and efforts to increase access to PAT are both high. Early clinical trials are focused on establishing the safety and utility of this treatment in eating disorders, and efficacy remains unclear.

Summary
High-quality published data to support the use of PAT for people with eating disorders remains lacking. Recent studies however suggest PAT has the potential to augment the efficacy of current interventions for these difficult-to-treat conditions.

Read more

Analgesic potential of macrodoses and microdoses of classical psychedelics in chronic pain sufferers: a population survey

Psychedelic‐assisted therapy for treating anxiety, depression, and existential distress in people with life‐threatening diseases

Client treatment preferences in psychedelic-assisted therapy for depression in participants with depressive symptoms

People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences

A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus

Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission